Edgewise Therapeutics Inc (NASDAQ:EWTX) price on current trading day, fall -7.31% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $24.59.
A look at the stock’s price movement, the close in the last trading session was $26.53, moving within a range at $23.3 and $27.04. The beta value (5-Year monthly) was 0.227. Turning to its 52-week performance, $38.12 and $14.90 were the 52-week high and 52-week low respectively. Overall, EWTX moved -5.89% over the past month.
Edgewise Therapeutics Inc’s market cap currently stands at around $2.34 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-02.
Turning to the stock’s technical picture we see that short term indicators suggest on average that EWTX is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend EWTX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
EWTX’s current price about -6.13% and -7.88% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 41.03, while 7-day volatility ratio is 9.74% and 8.67% in the 30-day chart. Further, Edgewise Therapeutics Inc (EWTX) has a beta value of 0.22, and an average true range (ATR) of 2.13. Analysts have given the company’s stock an average 52-week price target of $50, forecast between a low of $42 and high of $51. Looking at the price targets, the low is -70.8% off current price level while to achieve the yearly target high, price needs to move -107.4%. Nonetheless, investors will most likely welcome a -103.33% jump to $50 which is the analysts’ median price.
If we refocus on Edgewise Therapeutics Inc (NASDAQ:EWTX), historical trading data shows that trading volumes averaged 1.81 over the past 10 days and 1.06 million over the past 3 months. The company’s latest data on shares outstanding shows there are 94.84 million shares.
The 29.38% of Edgewise Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 78.78% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.73 million on 2025-02-28, giving us a short ratio of 8.97. The data shows that as of 2025-02-28 short interest in Edgewise Therapeutics Inc (EWTX) stood at 1338.0 of shares outstanding, with shares short rising to 7.06 million registered in 2025-01-31. Current price change has pushed the stock -7.90% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the EWTX stock continues to rise going into the next quarter.
